Rockaway Township, NJ, United States of America

Federico C Gaeta


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1985-1991

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Federico C Gaeta: Innovator in Antiglaucoma Treatments**

Introduction

Federico C Gaeta is a notable inventor based in Rockaway Township, Morris County, NJ, recognized for his significant contributions to the field of pharmaceutical innovation. With a total of five patents to his name, Gaeta has made remarkable advancements, particularly in the development of antiglaucoma agents.

Latest Patents

Among Gaeta's prominent inventions are his latest patents, which focus on antiglaucoma agents. These include pharmaceutical compositions and methods for reducing intraocular pressure by topically applying a carboxyalkyl dipeptide. His work in this area showcases his dedication to addressing critical health issues linked to glaucoma, a condition that can lead to serious vision loss.

Career Highlights

Throughout his career, Gaeta has been associated with several esteemed organizations, including the Schering Corporation. His role at such a reputable company underlines his expertise and the value of his contributions to pharmaceutical research and development.

Collaborations

Federico C Gaeta has also collaborated with other industry professionals, enhancing his work's impact. Notable coworkers include David R Andrews and Robert W Watkins, indicating a strong network of professionals in his field.

Conclusion

In summary, Federico C Gaeta continues to be a pioneering force in the pharmaceutical sector, particularly concerning antiglaucoma treatments. His innovative spirit and dedication to research reflect his important role in advancing healthcare solutions, making him a noteworthy inventor in the modern landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…